We herein present an overview of the upcoming 5th edition of the World Health Organization
Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid …

Importance Breast implant–associated anaplastic large cell lymphoma (BIA-ALCL), a rare
peripheral T-cell lymphoma, is increasing in incidence. However, many practitioners who …

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a recently
recognized non-Hodgkin lymphoma of T-cell origin. Despite the low incidence of this new …

Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is an uncommon type
of T-cell lymphoma. Although with a low incidence, the epidemiological data raised the …

The oncogenic events involved in breast implant–associated anaplastic large cell lymphoma
(BI-ALCL) remain elusive. To clarify this point, we have characterized the genomic …

Anaplastic large cell lymphomas (ALCLs) represent a group of CD30-positive T-cell non-
Hodgkin lymphomas with unifying morphological characteristics but variable clinical and …

Abstract Session 2 of the 2018 European Association of Hematopathology/Society for
Hematopathology Workshop focused on lymphomas arising in immune-privileged sites: both …

Abstract The 2022 European Association for Haematopathology/Society for
Hematopathology lymphoma workshop session on cavity-based lymphomas included sixty …

Late breast implant seroma may be the presentation of a breast implant-associated
anaplastic large cell lymphoma (BI-ALCL), which claims for a prompt recognition. However …

Breast implant–associated anaplastic large cell lymphoma is a malignancy of T lymphocytes
that is associated with the use of textured breast implants in both esthetic and reconstructive …